Rheumatology
From the Journals
Genetic Risk for Gout Raises Risk for Cardiovascular Disease Independent of Urate Level
Individuals at a high genetic risk for gout faced a significantly higher risk for cardiovascular disease than those at a lower genetic risk and...
Feature
Group Aims to Better Define ‘Extraordinarily Heterogeneous’ Mast Cell Activation Syndrome
There is controversy over the diagnostic criteria, with one proposed definition placing it at the center of many other co-occurring complex,...
From the Journals
Methotrexate in Preventing RA: Benefits in ACPA-Negative Patients, and Is It Cost Effective?
ACPA–negative individuals with clinically suspect arthralgia had reduced rates of RA development when treated with a 1-year course of methotrexate...
From the Journals
Weight Loss After Anti-Obesity Medications Linked to Reduced Gout Risk
The 5-year risk for incident gout was the lowest among patients in the fast weight loss group.
News from the FDA/CDC
FDA Approves Ustekinumab Biosimilar Otulfi
This is the fourth ustekinumab biosimilar approved in the United States.
From the Journals
Could Eyelid Imaging Aid Early Diagnosis of Sjögren Disease?
Patients with Sjögren disease had more damage to their oil-producing meibomian glands than people with other varieties of dry eye.
From the Journals
ILD Subtypes in Rheumatoid Arthritis Carry Different Risk Factor Profiles
Individuals who were male, seropositive, and smokers had a seven times higher risk for developing RA-UIP, the ILD subtype with a poor prognosis,...
Feature
Direct-to-Consumer Testing’s Expansion to Rheumatology Has Benefits but Potential Risks
Rheumatologists and lab specialists generally support consumers’ ability to access tests without a doctor’s order, but they remain aware of the...
News from the FDA/CDC
Bimekizumab Gains FDA Approval for Psoriatic Arthritis, Axial Spondyloarthritis
The drug is the first and only dual IL-17A and IL-17F inhibitor approved to treat four chronic immune-mediated inflammatory diseases.
Latest News
Muscle Relaxants for Chronic Pain: Where Is the Greatest Evidence?
They do not appear to be beneficial for low back pain, fibromyalgia, or headaches.
Feature
Patient Navigators in Rheumatology Set to Expand in Importance, Scope With New Medicare Codes
Rheumatology navigator programs vary in scope with different funding mechanisms. However, the prospect of getting paid by Medicare could open...